Experimental gene therapies like AMT‑130 lower toxic huntingtin protein and significantly slow Huntington’s disease, offering ...

Skyhawk Therapeutics announces interim results in patients from phase 1 clinical trial as a treatment for Huntington’s disease: Waltham, Massachusetts Thursday, January 29, 2026 ...

This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. The Huntington’s disease community celebrated a much-needed ...

Gene therapy is becoming a powerful way to treat challenging diseases that don’t respond to traditional treatments, and researchers now report the first success in modifying genes to slow Huntington’s ...

Huntington’s disease is a rare genetic disorder and a representative neurodegenerative disease, characterized by loss of motor control, cognitive decline, and psychiatric problems. An international ...

A novel gene therapy has been found to significantly slow the progression of Huntington’s disease, offering new hope to sufferers of the incurable disorder that destroys brain cells over time.

A team from the Faculty of Medicine and Health Sciences and the Institute of Neurosciences at the University of Barcelona ...

Researchers have made an important Huntington's disease discovery. They have found that the protein mutated in patients with Huntington's disease doesn't repair DNA as intended, impacting the ability ...

ElevateBio is seeking out partnerships for its lead gene therapy after the construct reduced the levels of a toxic protein in mice with Huntington’s disease by more than 80%. The therapy had no impact ...

Medically reviewed by Brigid Dwyer, MD Key Takeaways Huntington’s disease is a genetic condition that is inherited in an ...

Sadly, there is no cure for Huntington’s disease. But a couple new research papers suggests this may be about to change.